COVID-19 vaccine approved for emergency use on Tuesday after the U.S. Food and Drug Administration (FDA) released documents that did not raise any new issues about its safety or efficacy.Data on the vaccine submitted to the agency was in line with its guidance on emergency use authorization, FDA staff said in documents released ahead of Thursday’s meeting of outside experts.
First coronavirus vaccinations delivered in U.K. as historic mass rollout begins The experts will discuss whether the shot developed with German partner BioNTech SE should be authorized for emergency use.A two-dose vaccination was highly effective in preventing confirmed cases of COVID-19 at least seven days after the last dose, FDA staff said.The FDA said there was.